Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Genes Brain Behav ; 23(4): e12910, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39164860

ABSTRACT

Repeated cocaine use produces adaptations in brain function that contribute to long-lasting behaviors associated with cocaine use disorder (CUD). In rodents, the activity-regulated cytoskeleton-associated protein (Arc) can regulate glutamatergic synaptic transmission, and cocaine regulates Arc expression and subcellular localization in multiple brain regions, including the nucleus accumbens (NAc)-a brain region linked to CUD-related behavior. We show here that repeated, non-contingent cocaine administration in global Arc KO male mice produced a dramatic hypersensitization of cocaine locomotor responses and drug experience-dependent sensitization of conditioned place preference (CPP). In contrast to the global Arc KO mice, viral-mediated reduction of Arc in the adult male, but not female, NAc (shArcNAc) reduced both CPP and cocaine-induced locomotor activity, but without altering basal miniature or evoked glutamatergic synaptic transmission. Interestingly, cell type-specific knockdown of Arc in D1 dopamine receptor-expressing NAc neurons reduced cocaine-induced locomotor sensitization, but not cocaine CPP; whereas, Arc knockdown in D2 dopamine receptor-expressing NAc neurons reduced cocaine CPP, but not cocaine-induced locomotion. Taken together, our findings reveal that global, developmental loss of Arc produces hypersensitized cocaine responses; however, these effects cannot be explained by Arc's function in the adult mouse NAc since Arc is required in a cell type- and sex-specific manner to support cocaine-context associations and locomotor responses.


Subject(s)
Cocaine , Cytoskeletal Proteins , Nerve Tissue Proteins , Nucleus Accumbens , Animals , Nucleus Accumbens/metabolism , Nucleus Accumbens/drug effects , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Male , Mice , Female , Cocaine/pharmacology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D1/genetics , Locomotion/drug effects , Cocaine-Related Disorders/metabolism , Cocaine-Related Disorders/genetics , Cocaine-Related Disorders/physiopathology , Mice, Inbred C57BL , Neurons/metabolism , Neurons/drug effects , Synaptic Transmission
2.
Nat Commun ; 15(1): 5971, 2024 Aug 08.
Article in English | MEDLINE | ID: mdl-39117647

ABSTRACT

Powerful associations that link drugs of abuse with cues in the drug-paired environment often serve as prepotent relapse triggers. Drug-associated contexts and cues activate ensembles of nucleus accumbens (NAc) neurons, including D1-class medium spiny neurons (MSNs) that typically promote, and D2-class MSNs that typically oppose, drug seeking. We found that in mice, cocaine conditioning upregulated transiently the activity-regulated transcription factor, Neuronal PAS Domain Protein 4 (NPAS4), in a small subset of NAc neurons. The NPAS4+ NAc ensemble was required for cocaine conditioned place preference. We also observed that NPAS4 functions within NAc D2-, but not D1-, MSNs to support cocaine-context associations and cue-induced cocaine, but not sucrose, seeking. Together, our data show that the NPAS4+ ensemble of NAc neurons is essential for cocaine-context associations in mice, and that NPAS4 itself functions in NAc D2-MSNs to support cocaine-context associations by suppressing drug-induced counteradaptations that oppose relapse-related behaviour.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors , Cocaine , Cues , Neurons , Nucleus Accumbens , Animals , Nucleus Accumbens/metabolism , Nucleus Accumbens/drug effects , Cocaine/pharmacology , Basic Helix-Loop-Helix Transcription Factors/metabolism , Basic Helix-Loop-Helix Transcription Factors/genetics , Mice , Male , Neurons/metabolism , Neurons/drug effects , Mice, Inbred C57BL , Drug-Seeking Behavior , Receptors, Dopamine D2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL